NYSE:MYOV
Delisted

Myovant Sciences Stock News

etoro logo Buy MYOV
*Your capital is at risk
$26.98
+0 (+0%)
At Close: Jun 08, 2023

Top Picks 2020- Myovant Sciences Ltd. MYOV

10:00am, Wednesday, 22'nd Jan 2020
Myovant Sciences Ltd. (MYOV) offers a new drug "pipeline in a pill", asserts biotech expert Jay Silverman, contributing editor to The Medical Technology Stock Letter.

The Cutting Edge Of Systematic Investing

05:48pm, Tuesday, 21'st Jan 2020
Systematic or Quantitative Investing continues to be a bigger part of the market as it delivers stronger market-beating returns fairly consistently. Experts oft
Myovant Sciences Ltd (NYSE:MYOV) insider Kim Sablich sold 4,840 shares of the business’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $14.04, for a

Why Myovant Stock Fell 5% in 2019

02:40pm, Monday, 13'th Jan 2020
Shares swung wildly as investors tried to guess at the long-run prospects of promising new drug treatments for prostate cancer.
BASEL, Switzerland, Jan. 06, 2020 -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer,.
Myovant confirmed the closing of the previously announced loan facility from Sumitomo Dainippon Pharma, now increased to US$400 million. The post Myovant Sciences Confirms Closing of US$400 Million Lo
Low-interest (3-month LIBOR plus 3%) loan facility from Sumitomo Dainippon Pharma increased to allow repayment of pre-existing debtHiroshi Nomura, President, CEO, and.
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Anyone researching Myovant Sciences Ltd. (NYSE:MYOV) might want to consider the historical volatility of the share...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE